| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |